Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: To assess the impact of adding statin (atorvastatin) and/or aspirin on clinical deterioration in patients infected with SARS-CoV-2 who require hospitalisation. The safety of these drugs in COVID-19 patients will also be evaluated. TRIAL DESIGN: This is a single-centre, prospective, four-...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Trials
Główni autorzy: Ghati, Nirmal, Roy, Ambuj, Bhatnagar, Sushma, Bhati, Sumit, Bhushan, Sudha, Mahendran, Manjit, Thakur, Abhishek, Tiwari, Pawan, Dwivedi, Tanima, Mani, Kalaivani, Gupta, Ritu, Mohan, Anant, Garg, Rakesh, Saxena, Anita, Guleria, Randeep, Deepti, Siddharthan
Format: Artigo
Język:Inglês
Wydane: BioMed Central 2020
Hasła przedmiotowe:
Letter
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7598224/
https://ncbi.nlm.nih.gov/pubmed/33126910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04840-y
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy